CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Indies Pharma Jamaica Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Indies Pharma Jamaica Ltd
Unit-5 Montego Bay Trade Centre
, Howard Cooke Blvd,, West Indies.
Phone: (876) 940-7984p:876 940-7984 MONTEGO BAY, Jamaica Ticker: INDIESINDIES

Business Summary
Indies Pharma Jamaica Limited is a Jamaica-based pharmaceutical company. The Company is engaged in the distribution and retailing of pharmaceutical and auxiliary products. The Company distributes over 150 prescription and non-prescription or over the counter generic pharmaceutical products for Bioprist Holdings Limited under the Bioprist Pharmaceuticals brand in addition to other products being sold under the orthopedic and joint rehabilitation segment. The Company services customers across all 14 parishes of the island, including over 400 pharmacies, private and public hospitals and government agencies, including the National Health Fund as well as medical practitioners and directly to individual end users. Its products include Indapamide SR 1.5 milligram (mg), Amlodipine 5mg, Amlodipine 10mg, Amlodipine 5mg + Valsartan 80mg, Amlodipine 5mg + Valsartan 160mg, Amlodipine 10mg + Valsartan 160mg, Valsartan 80mg, Valsartan 160mg, Domperidone 10mg, Tamoxifen 10mg and Metformin 500mg.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
1/31/202410/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman, President, Chief Executive Officer, Founder of the Company GunaMuppuri
Co-Founder, Chief Operating Officer, Executive Director VishnuMuppuri
Non-Executive Independent Director KevinDonaldson
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 71 (As of 10/31/2023)
Outstanding Shares: 1,332,536,649 (As of 1/31/2024)
Stock Exchange: JAM
Fax Number: (876) 940-7980


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024